<PAGE>
FORM 10-Q/A
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C, 20549
(X) QUARTERLY REPORT UNDER SECTION 13 OR 15 (D) OF THE
SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTER PERIOD ENDED JANUARY 31, 1996
----------------
OR
( ) TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE
SECURITIES EXCHANGE ACT OF 1934
For the transition period from __________ to ____________
Commission File Number
0-14003
ROTECH MEDICAL CORPORATION
--------------------------
(Exact name of Registrant as specified on its Charter)
Florida 59-2115892
- -------------------------- ---------------------
(State of jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
4506 L.B. McLeod Road, Suite F, Orlando, Florida 32811
- ----------------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code: (407) 841-2115
- ----------------------------------------------------------------------
Indicate by check mark whether the Registrant (1) has filed all reports
required to be filed by Section 13 or 15 (d) of the Securities and
Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the Registrant was required to file such reports), and (2)
has been subject to such filing requirements for the past 90 days.
YES X NO
----- ------
Indicate the number of shares outstanding of each class of issuer's
classes of common stock as of March 13, 1996: 12,389,321
<PAGE>
ROTECH MEDICAL CORPORATION AND SUBSIDIARIES
- -----------------------------------------------------------------
Signature
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned thereunto duly authorized.
ROTECH MEDICAL CORPORATION
a Florida Corporation
Dated: May 14, 1996 By: /s/ Rebecca R. Irish
-------------------- -------------------------------
Rebecca R. Irish, Treasurer
and Chief Financial Officer
2
<TABLE> <S> <C>
<PAGE>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM 2ND QUARTER
FORM 10-Q AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL
STATEMENTS.
</LEGEND>
<S> <C> <C>
<PERIOD-TYPE> 6-MOS 3-MOS
<FISCAL-YEAR-END> JUL-31-1995 JUL-31-1995
<PERIOD-START> AUG-01-1995 NOV-01-1995
<PERIOD-END> JAN-31-1996 JAN-31-1996
<CASH> 3,547,339 3,547,339
<SECURITIES> 0 0
<RECEIVABLES> 65,556,906 65,556,906
<ALLOWANCES> 0 0
<INVENTORY> 16,848,535 16,848,535
<CURRENT-ASSETS> 90,218,594 90,218,594
<PP&E> 66,863,661 66,863,661
<DEPRECIATION> 0 0
<TOTAL-ASSETS> 274,466,775 274,466,775
<CURRENT-LIABILITIES> 109,021,102 109,021,102
<BONDS> 0 0
0 0
0 0
<COMMON> 2,320 2,320
<OTHER-SE> 161,548,153 161,548,153
<TOTAL-LIABILITY-AND-EQUITY> 274,466,775 274,466,775
<SALES> 106,582,378 61,463,199
<TOTAL-REVENUES> 106,582,378 61,463,199
<CGS> 29,030,503 16,782,626
<TOTAL-COSTS> 29,030,503 16,782,626
<OTHER-EXPENSES> 61,502,391 35,956,021
<LOSS-PROVISION> 0 0
<INTEREST-EXPENSE> 1,336,721 895,758
<INCOME-PRETAX> 14,712,763 7,828,794
<INCOME-TAX> 5,458,435 2,897,599
<INCOME-CONTINUING> 9,254,328 4,931,195
<DISCONTINUED> 0 0
<EXTRAORDINARY> 0 0
<CHANGES> 0 0
<NET-INCOME> 9,254,328 4,931,195
<EPS-PRIMARY> 0.76 0.40
<EPS-DILUTED> 0 0
</TABLE>
